ARCHIVES

“Harm-Reduction” Products No Proven, IOM Report Says.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

BMS Settles Charges Of Obstructing Generics

March 14, 2003

To Industry for Development, NDA

November 18, 1977

ASCO Explores White, Minority Cancer Problem

July 13, 1990

Maryland to Use $1B In Tobacco Funds For Cancer Research, Anti-Smoking Program

June 4, 1999

Increase In Recommended Levels, OMB’s Forward Funding Create Shortfall In Center’s Budget

April 19, 1985

ASCO Highlights Six Studies From Meeting To Showcase Advances In Cancer Care

May 30, 2008